(Q39250942)

English

Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Ahmet Taner Sümbül

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ahmet Sezer

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hüseyin Abalı

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Fatih Köse

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ilhami Gültepe

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hüseyin Mertsoylu

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sadık Muallaoğlu

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Özgür Özyılkan

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

13 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1531-1535

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Systemic inflammatory response in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Clinical significance of preoperative inflammatory parameters in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Circulating tumor cells as biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable?

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11255-014-0664-7

21 January 2018

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24526335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24526335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24526335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24526335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-014-0664-7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39250942&oldid=1856227975"